Published in J Nutr on December 01, 2004
Islet beta cell failure in type 2 diabetes. J Clin Invest (2006) 7.67
Glucose metabolism in vivo in four commonly used inbred mouse strains. Diabetes (2008) 2.38
The biological control of voluntary exercise, spontaneous physical activity and daily energy expenditure in relation to obesity: human and rodent perspectives. J Exp Biol (2011) 2.34
n-3 PUFA improves fatty acid composition, prevents palmitate-induced apoptosis, and differentially modifies B cell cytokine secretion in vitro and ex vivo. J Lipid Res (2010) 1.19
Relevance of animal models to human eating disorders and obesity. Psychopharmacology (Berl) (2008) 1.13
Effect of long-term caloric restriction on oxygen consumption and body temperature in two different strains of mice. Mech Ageing Dev (2007) 1.09
Putting desire on a budget: dopamine and energy expenditure, reconciling reward and resources. Front Integr Neurosci (2012) 1.00
A low-carbohydrate high-fat diet increases weight gain and does not improve glucose tolerance, insulin secretion or β-cell mass in NZO mice. Nutr Diabetes (2016) 0.94
Cholecystokinin knockout mice are resistant to high-fat diet-induced obesity. Gastroenterology (2010) 0.89
Behavioral responses to orexin, orexin receptor gene expression, and spontaneous physical activity contribute to individual sensitivity to obesity. Am J Physiol Endocrinol Metab (2012) 0.88
High and low activity rats: elevated intrinsic physical activity drives resistance to diet-induced obesity in non-bred rats. Obesity (Silver Spring) (2013) 0.87
ATR-FTIR spectroscopy reveals genomic loci regulating the tissue response in high fat diet fed BXD recombinant inbred mouse strains. BMC Genomics (2013) 0.85
Wheel access does not attenuate weight gain in mice fed high-fat or high-CHO diets. Med Sci Sports Exerc (2010) 0.85
Open chromatin profiling in mice livers reveals unique chromatin variations induced by high fat diet. J Biol Chem (2014) 0.85
Genetically altering organismal metabolism by leptin-deficiency benefits a mouse model of amyotrophic lateral sclerosis. Hum Mol Genet (2014) 0.84
Lifespan modulation in mice and the confounding effects of genetic background. J Genet Genomics (2014) 0.84
Dissociation of hepatic insulin resistance from susceptibility of nonalcoholic fatty liver disease induced by a high-fat and high-carbohydrate diet in mice. Am J Physiol Gastrointest Liver Physiol (2014) 0.84
The liver: Key in regulating appetite and body weight. Adipocyte (2012) 0.79
Designing phenotyping studies for genetically engineered mice. Vet Pathol (2011) 0.78
ABCG5/G8 deficiency in mice reduces dietary triacylglycerol and cholesterol transport into the lymph. Lipids (2015) 0.77
High fat feeding unmasks variable insulin responses in male C57BL/6 mouse substrains. J Endocrinol (2017) 0.75
Molecular phenotyping of multiple mouse strains under metabolic challenge uncovers a role for Elovl2 in glucose-induced insulin secretion. Mol Metab (2017) 0.75
Innate Mucosal Immune System Response of BALB/c vs C57BL/6 Mice to Injury in the Setting of Enteral and Parenteral Feeding. JPEN J Parenter Enteral Nutr (2014) 0.75
Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA (2008) 13.69
Long-term persistence of hormonal adaptations to weight loss. N Engl J Med (2011) 5.51
Insulin levels in insulin resistance: phantom of the metabolic opera? Med J Aust (2006) 5.33
Evaluating the glucose tolerance test in mice. Am J Physiol Endocrinol Metab (2008) 3.21
Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes. Nature (2012) 2.83
Reactive oxygen species enhance insulin sensitivity. Cell Metab (2009) 2.77
Tumor necrosis factor alpha-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling. Cell Metab (2006) 2.43
The effect of rate of weight loss on long-term weight management: a randomised controlled trial. Lancet Diabetes Endocrinol (2014) 2.30
Effectiveness and side effects of thiazolidinediones for type 2 diabetes: real-life experience from a tertiary hospital. Med J Aust (2004) 2.14
Targeted reduction of advanced glycation improves renal function in obesity. Kidney Int (2011) 1.63
Differential effect of inbred mouse strain (C57BL/6, DBA/2, 129T2) on insulin secretory function in response to a high fat diet. J Endocrinol (2005) 1.51
Increased dietary fat promotes islet amyloid formation and beta-cell secretory dysfunction in a transgenic mouse model of islet amyloid. Diabetes (2003) 1.49
Public health campaigns and obesity - a critique. BMC Public Health (2011) 1.35
Of mice and men: the evolving phenotype of aromatase deficiency. Trends Endocrinol Metab (2006) 1.27
Pharmacotherapy for obesity. Drugs (2005) 1.24
Comparison of insulin secretory function in two mouse models with different susceptibility to beta-cell failure. Endocrinology (2002) 1.18
Deficiency in interferon-gamma results in reduced body weight and better glucose tolerance in mice. Endocrinology (2011) 1.17
The defence of body weight: a physiological basis for weight regain after weight loss. Clin Sci (Lond) (2013) 1.16
2011 Young Investigator Award winner: Increased fat mass is associated with high levels of low back pain intensity and disability. Spine (Phila Pa 1976) (2011) 1.16
Is there an obesity paradox after percutaneous coronary intervention in the contemporary era? An analysis from a multicenter Australian registry. JACC Cardiovasc Interv (2010) 1.14
Advanced glycation end products are direct modulators of β-cell function. Diabetes (2011) 1.14
Safety of drug therapies used for weight loss and treatment of obesity. Drug Saf (2006) 1.12
Adaptive responses in hypothalamic neuropeptide Y in the face of prolonged high-fat feeding in the rat. J Neurochem (2004) 1.11
Liver-specific suppressor of cytokine signaling-3 deletion in mice enhances hepatic insulin sensitivity and lipogenesis resulting in fatty liver and obesity. Hepatology (2010) 1.10
One-year weight maintenance after significant weight loss in healthy overweight and obese subjects: does diet composition matter? Am J Clin Nutr (2009) 1.05
T-cell protein tyrosine phosphatase attenuates STAT3 and insulin signaling in the liver to regulate gluconeogenesis. Diabetes (2010) 1.03
Ciliary neurotrophic factor suppresses hypothalamic AMP-kinase signaling in leptin-resistant obese mice. Endocrinology (2006) 1.03
The deletion variant of nicotinamide nucleotide transhydrogenase (Nnt) does not affect insulin secretion or glucose tolerance. Endocrinology (2009) 1.00
The hexosamine biosynthesis pathway regulates insulin secretion via protein glycosylation in mouse islets. Arch Biochem Biophys (2002) 0.99
Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathy. Am J Physiol Renal Physiol (2009) 0.96
The relationship between body composition and structural changes at the knee. Rheumatology (Oxford) (2010) 0.94
Association of weight gain with incident knee pain, stiffness, and functional difficulties: a longitudinal study. Arthritis Care Res (Hoboken) (2013) 0.94
Targeted GLUT-4 deficiency in the heart induces cardiomyocyte hypertrophy and impaired contractility linked with Ca(2+) and proton flux dysregulation. J Mol Cell Cardiol (2009) 0.94
Relationship between obesity and foot pain and its association with fat mass, fat distribution, and muscle mass. Arthritis Care Res (Hoboken) (2012) 0.94
Effect of weight loss and ketosis on postprandial cholecystokinin and free fatty acid concentrations. Am J Clin Nutr (2008) 0.92
The nuclear receptor, Nor-1, markedly increases type II oxidative muscle fibers and resistance to fatigue. Mol Endocrinol (2012) 0.92
Position statement of the Australian Diabetes Society: individualisation of glycated haemoglobin targets for adults with diabetes mellitus. Med J Aust (2009) 0.91
The role of liver fructose-1,6-bisphosphatase in regulating appetite and adiposity. Diabetes (2012) 0.91
Proteoglycans synthesized and secreted by pancreatic islet beta-cells bind amylin. Arch Biochem Biophys (2003) 0.90
Obesity and trends in life expectancy. J Obes (2012) 0.89
Fructose-1,6-bisphosphatase overexpression in pancreatic beta-cells results in reduced insulin secretion: a new mechanism for fat-induced impairment of beta-cell function. Diabetes (2008) 0.89
Socs1 deficiency enhances hepatic insulin signaling. J Biol Chem (2005) 0.89
Effects and clinical potential of very-low-calorie diets (VLCDs) in type 2 diabetes. Diabetes Res Clin Pract (2009) 0.88
Reduction of proteinuria by rosiglitazone in non-diabetic renal disease. Nephrology (Carlton) (2008) 0.88
The effect of tissue type-plasminogen activator deletion and associated fibrin(ogen) deposition on macrophage localization in peritoneal inflammation. Thromb Haemost (2006) 0.87
Increased glucose production in mice overexpressing human fructose-1,6-bisphosphatase in the liver. Am J Physiol Endocrinol Metab (2008) 0.86
Benefit-risk assessment of orlistat in the treatment of obesity. Drug Saf (2014) 0.86
High passage MIN6 cells have impaired insulin secretion with impaired glucose and lipid oxidation. PLoS One (2012) 0.85
Rhythmic neuronal activity in S2 somatosensory and insular cortices contribute to the initiation of absence-related spike-and-wave discharges. Epilepsia (2012) 0.85
Methazolamide is a new hepatic insulin sensitizer that lowers blood glucose in vivo. Diabetes (2012) 0.85
Expression of human fructose-1,6-bisphosphatase in the liver of transgenic mice results in increased glycerol gluconeogenesis. Endocrinology (2006) 0.85
Hope and fear for new classes of type 2 diabetes drugs: is there preclinical evidence that incretin-based therapies alter pancreatic morphology? J Endocrinol (2014) 0.85
High glucose-induced impairment in insulin secretion is associated with reduction in islet glucokinase in a mouse model of susceptibility to islet dysfunction. J Mol Endocrinol (2005) 0.84
Effects of oxaliplatin on mouse myenteric neurons and colonic motility. Front Neurosci (2013) 0.84
A primary defect in glucose production alone cannot induce glucose intolerance without defects in insulin secretion. J Endocrinol (2011) 0.83
High-fat-fed obese glutathione peroxidase 1-deficient mice exhibit defective insulin secretion but protection from hepatic steatosis and liver damage. Antioxid Redox Signal (2014) 0.83
State of the science: VLED (Very Low Energy Diet) for obesity. Asia Pac J Clin Nutr (2006) 0.82
Glucose homeostasis can be differentially modulated by varying individual components of a western diet. J Nutr Biochem (2013) 0.82
Elevated SNAP-25 is associated with fatty acid-induced impairment of mouse islet function. Biochem Biophys Res Commun (2004) 0.81
Less fat reduction per unit weight loss in type 2 diabetic compared with nondiabetic obese individuals completing a very-low-calorie diet program. Metabolism (2011) 0.81
Normal muscle glucose uptake in mice deficient in muscle GLUT4. J Endocrinol (2012) 0.80
Molecular mechanisms of increased glucose production: identifying potential therapeutic targets. J Investig Med (2004) 0.80
Neprilysin deficiency protects against fat-induced insulin secretory dysfunction by maintaining calcium influx. Diabetes (2013) 0.79
Focal administration of neuropeptide Y into the S2 somatosensory cortex maximally suppresses absence seizures in a genetic rat model. Epilepsia (2012) 0.79
The liver: Key in regulating appetite and body weight. Adipocyte (2012) 0.79
The New Zealand obese mouse model of obesity insulin resistance and poor breeding performance: evaluation of ovarian structure and function. J Endocrinol (2011) 0.79
NPY5R antagonism does not augment the weight loss efficacy of orlistat or sibutramine. Obesity (Silver Spring) (2007) 0.78
Exercise-induced muscle glucose uptake in mice with graded, muscle-specific GLUT-4 deletion. Physiol Rep (2013) 0.78
Sex differences in the relationship between bone mineral density and tibial cartilage volume. Rheumatology (Oxford) (2010) 0.77
Investigational agents that protect pancreatic islet beta-cells from failure. Expert Opin Investig Drugs (2005) 0.77
Hypoxanthine-xanthine oxidase down-regulates GLUT1 transcription via SIRT1 resulting in decreased glucose uptake in human placenta. J Endocrinol (2012) 0.77
Impaired cavernous reinnervation after penile nerve injury in rats with features of the metabolic syndrome. J Sex Med (2009) 0.77
Relationship between mental health and foot pain. Arthritis Care Res (Hoboken) (2014) 0.76
Safe year-long use of a very-low-calorie diet for the treatment of severe obesity. Med J Aust (2008) 0.76
When does severe childhood obesity become a child protection issue? Comment. Med J Aust (2009) 0.75
Endocrine aspects of obesity. Mol Cell Endocrinol (2009) 0.75
Obesity and weight management at menopause. Aust Fam Physician (2017) 0.75
Activation of PI 3-kinase by the hexosamine biosynthesis pathway. Mol Cell Endocrinol (2002) 0.75